Advanced Glycation End Products Market Synopsis

Advanced Glycation End Products Market Size Was Valued at USD 2.7 Billion in 2023, and is Projected to Reach USD 4.4 Billion by 2032, Growing at a CAGR of 5.5% From 2024-2032.

Advanced Glycation End Products (AGEs) Market relates to the economic activity in relation to complex which are products of the condensation of sugars with proteins or lipids and alter these macromolecules. AGEs are related to numerous diseases, such as diabetes and associated complications, cardiovascular diseases and neurodegenerative diseases. This market includes diagnotic, analytical and therapeutic application of AGEs and related products and services which is fast developing due to increased understanding of the effect of AGEs in disease processes.

• The market for Advanced Glycation End Products has been on a growth trajectory over the years owing to factors such as the growing incidence of diseases connected with aging, diabetes and lifestyle choices. AGEs are on record to contribute towards free radical generation and inflammation, processes central to the development of many human diseases. Lately, people became much more conscious about their health and, therefore, there is increased need for diagnostic and therapeutic procedures that will help to detect and manage the impact of AGEs. Moreover, the investigation of effects of AGEs on health is ongoing, and hence AGE research draws more attention to the introduction of new AGE detection and treatment technologies.
• In addition, recent innovation in techniques is helping to discover new easier and more accurate techniques for the determination of AGEs in biological fluids. Apart from improving the diagnostic reliability these innovations can elucidate the mechanistic approach to diseases affected by AGEs. Therefore, it has led to a growing trend of giant pharmaceutical and biotechnology companies in spending their resources toward the development of targeted therapies for AGE-related diseases, and driving the market persistently. 

Advanced Glycation End Products Market Trend Analysis

Rising Awareness and Research into AGEs

• Actually, there is one trend that became quite evident in the modern context of the Advanced Glycation End Products market – the growth of the public awareness among both, doctors and patients, about the negative impact of AGEs. This has been made possible by constant discovery of relationship between AGEs and more diseases such as diabetes, Alzheimer’s disease, and cardiovascular diseases among others. As the research on AGEs and health effects are exposed, the clinicians are incorporating the AGE assessment in clinical settings. Consumer demand for preventative healthcare is also on the rise and as a result; there are emerging diagnostic products and treatments devised for the purpose of reducing AGE in the human body.

Expansion into Emerging Markets

• The opportunities for growth for the Advanced Glycation End Products industry and especially, for markets of emerging economies are evident.. With the increased access to HE, as well as increased awareness of chronic diseases in countries like India, Brazil and China, the market for AGE related diagnosing and therapeutic aids and devices remain high. These markets offer companies a chance to enter and supply a huge populace with products as it increasingly becomes informed of the detrimental effects of AGEs. Thus, it is possible to target the markets and deliver the AGE management solutions that meet these markets’ needs and build all necessary partnerships using local resources.

Advanced Glycation End Products Market Segment Analysis:

Advanced Glycation End Products Market is segmented on the basis of type, application and end user.

By Type, Non-Fluorescent AGEs segment is expected to dominate the market during the forecast period

• Analyzing the market of Advanced Glycation End Products, the report identifies the Non-Fluorescent AGEs segment as a leader in the niche till 2024. Non-fluorescent AGEs are also implicated in chronic diseases, and development of new analytical methods for their measurement is allowing for better identification of such compounds. Due to healthcare professionals’ desire of improving diagnostics of AGE-associated illnesses, there will be an increase in the consumption of non-fluorescent AGEs. This segment’s prospects are further enhanced by rising research efforts in the discovery of specific drugs that can actually help to decrease extracellular non-fluorescent AGEs in bodies.

By Application, Diabetic Complications segment expected to held the largest share

• Concerning the application, it is projected that the Diabetic Complications segment will have the largest market share in Advanced Glycation End Products. This is due to the fact that diabetes is now a worldwide disease, and the complications that come with long time exposure to high glucose levels. Due to the fact that AGEs are involved in the development and progression of complication such as neuropathy, nephropathy and retinopathy in diabetes patient, there is an increased need for management solutions. Moreover, the rising concern for diabetes control and prevention is the main factor promoting the development of diagnostic products and therapies for targeting AGEs, thus strengthening this segment in the market.

Advanced Glycation End Products Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• The Advanced Glycation End Products market is anticipated to witness North America as the leading region in the year 2023 followed by South America who would occupy slightly below 40% market share. Potential factors explaining for the prevalence of the region include increased occurrence of diabetes and obesity which is strongly associated with formation of AGE products. Also for instance, North America has a highly developed healthcare system, significant expenditure on the research and development front and a perceived emphasis on the treatment of chronic ailments. It is due to reasons such as availability of key market players and rising number of clinical researches conducted in the area that establishes the region in the leading fold in the market.

Active Key Players in the Advanced Glycation End Products Market

• Abbott Laboratories (USA)
• Alpco Diagnostics (USA)
• Bio-Rad Laboratories, Inc. (USA)
• Cayman Chemical Company (USA)
• Cleveland Clinic (USA)
• Enzo Life Sciences, Inc. (USA)
• Genway Biotech, Inc. (USA)
• LifeSpan BioSciences, Inc. (USA)
• Medix Biochemica (Finland)
• MilliporeSigma (USA)
• MyBioSource, Inc. (USA)
• R&D Systems, Inc. (USA)
• Thermo Fisher Scientific Inc. (USA)
• VivaCell Biotechnology (Germany)
• Wako Chemicals USA, Inc. (USA), Other key Players.

Key Industry Developments in the Advanced Glycation End Products Market:

• In July 2023, L'Oréal S.A. acquired Youth Sciences International (YSI), which granted it access to its anti-aging ingredients and technologies, particularly those that target AGEs. The purpose of this action is to enhance L'Oréal's research and development capabilities in the development of innovative anti-aging products.
• In April 2023, The WASO Bihada Lock Moisturiser was introduced by Shiseido Company. It is composed of ingredients that are designed to protect the skin from damage and prevent the formation of AGEs. It is intended to be non-greasy and lightweight, making it suitable for all skin types.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Advanced Glycation End Products Market by Type
 4.1 Advanced Glycation End Products Market Snapshot and Growth Engine
 4.2 Advanced Glycation End Products Market Overview
 4.3 Non-Fluorescent AGEs
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Non-Fluorescent AGEs: Geographic Segmentation Analysis
 4.4 Fluorescent AGEs
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Fluorescent AGEs: Geographic Segmentation Analysis

Chapter 5: Advanced Glycation End Products Market by Application
 5.1 Advanced Glycation End Products Market Snapshot and Growth Engine
 5.2 Advanced Glycation End Products Market Overview
 5.3 Cancer
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Cancer: Geographic Segmentation Analysis
 5.4 Bone Diseases
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Bone Diseases: Geographic Segmentation Analysis
 5.5 Diabetic Complications
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Diabetic Complications: Geographic Segmentation Analysis
 5.6 Neurodegenerative Diseases
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Neurodegenerative Diseases: Geographic Segmentation Analysis
 5.7 Other Applications
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Other Applications: Geographic Segmentation Analysis

Chapter 6: Advanced Glycation End Products Market by End User
 6.1 Advanced Glycation End Products Market Snapshot and Growth Engine
 6.2 Advanced Glycation End Products Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Specialty Clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Specialty Clinics: Geographic Segmentation Analysis
 6.5 Other End-Users
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Other End-Users: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Advanced Glycation End Products Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 ABBOTT LABORATORIES (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 ALPCO DIAGNOSTICS (USA)
 7.4 BIO-RAD LABORATORIES INC (USA)
 7.5 CAYMAN CHEMICAL COMPANY (USA)
 7.6 CLEVELAND CLINIC (USA)
 7.7 ENZO LIFE SCIENCES INC (USA)
 7.8 GENWAY BIOTECH INC (USA)
 7.9 LIFESPAN BIOSCIENCES INC (USA)
 7.10 MEDIX BIOCHEMICA (FINLAND)
 7.11 MILLIPORESIGMA (USA)
 7.12 MYBIOSOURCE INC (USA)
 7.13 R&D SYSTEMS INC (USA)
 7.14 THERMO FISHER SCIENTIFIC INC (USA)
 7.15 VIVACELL BIOTECHNOLOGY (GERMANY)
 7.16 WAKO CHEMICALS USA INC (USA)
 7.17 OTHER KEY PLAYERS

Chapter 8: Global Advanced Glycation End Products Market By Region
 8.1 Overview
 8.2. North America Advanced Glycation End Products Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 Non-Fluorescent AGEs
  8.2.4.2 Fluorescent AGEs
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Cancer
  8.2.5.2 Bone Diseases
  8.2.5.3 Diabetic Complications
  8.2.5.4 Neurodegenerative Diseases
  8.2.5.5 Other Applications
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Hospitals
  8.2.6.2 Specialty Clinics
  8.2.6.3 Other End-Users
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Advanced Glycation End Products Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 Non-Fluorescent AGEs
  8.3.4.2 Fluorescent AGEs
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Cancer
  8.3.5.2 Bone Diseases
  8.3.5.3 Diabetic Complications
  8.3.5.4 Neurodegenerative Diseases
  8.3.5.5 Other Applications
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Hospitals
  8.3.6.2 Specialty Clinics
  8.3.6.3 Other End-Users
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Advanced Glycation End Products Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 Non-Fluorescent AGEs
  8.4.4.2 Fluorescent AGEs
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Cancer
  8.4.5.2 Bone Diseases
  8.4.5.3 Diabetic Complications
  8.4.5.4 Neurodegenerative Diseases
  8.4.5.5 Other Applications
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Hospitals
  8.4.6.2 Specialty Clinics
  8.4.6.3 Other End-Users
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Advanced Glycation End Products Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 Non-Fluorescent AGEs
  8.5.4.2 Fluorescent AGEs
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Cancer
  8.5.5.2 Bone Diseases
  8.5.5.3 Diabetic Complications
  8.5.5.4 Neurodegenerative Diseases
  8.5.5.5 Other Applications
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Hospitals
  8.5.6.2 Specialty Clinics
  8.5.6.3 Other End-Users
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Advanced Glycation End Products Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 Non-Fluorescent AGEs
  8.6.4.2 Fluorescent AGEs
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Cancer
  8.6.5.2 Bone Diseases
  8.6.5.3 Diabetic Complications
  8.6.5.4 Neurodegenerative Diseases
  8.6.5.5 Other Applications
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Hospitals
  8.6.6.2 Specialty Clinics
  8.6.6.3 Other End-Users
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Advanced Glycation End Products Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 Non-Fluorescent AGEs
  8.7.4.2 Fluorescent AGEs
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Cancer
  8.7.5.2 Bone Diseases
  8.7.5.3 Diabetic Complications
  8.7.5.4 Neurodegenerative Diseases
  8.7.5.5 Other Applications
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Hospitals
  8.7.6.2 Specialty Clinics
  8.7.6.3 Other End-Users
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research